Price target
25.860.00 0.00%
The 7 analysts offering 1 year price forecasts for NVCR have a max estimate of — and a min estimate of —.
Analyst rating
Based on 7 analysts giving stock ratings to NVCR in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
NVCR EPS for the last quarter is −0.45 USD despite the estimation of −0.52 USD. In the next quarter EPS is expected to reach −0.42 USD. Track more of NovoCure Limited financials and stay on top of what is up with the company.
In the next quarter NovoCure Limited revenue is expected to reach 131.44 M USD. Check out NovoCure Limited revenue and earnings and make informed decisions.
According to analysts, NVCR price target is 25.86 USD with a max estimate of 42.00 USD and a min estimate of 15.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with NVCR news and stock market news.
We've gathered opinions of 7 analysts rating NVCR stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.